Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
2h agoThe Metals Company and Allseas Sign Commercial Agreement for the First Offshore Nodule Recovery Operation
2h agoAn Exclusive Invitation and a Global Platform: Almonty's CEO Welcomes Eligible Shareholders on a Journey to South Korea – and Prepares to Speak at BofA Securities and CMI Conferences
3h agoCaris Life Sciences Publishes Study Showing Whole Exome Measurement of Tumor Mutational Burden Results in Increased Overall Survival Compared to Estimates from Targeted Gene Panels
3h agoTurkcell Iletisim Hizmetleri: First Quarter 2026 Results
3h agoNexTel Medical Corp Enters Final Stage for Commercial Launch; Sets Sights on Revenue Generation and OTCQB Uplist
Percheron Therapeutics Limited logo

Percheron Therapeutics Limited

About

Percheron Therapeutics Limited — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 14 2026
Results of Entitlement Offer
Mar 16 2026
Prospectus - Non-renounceable Entitlement Offer
Mar 16 2026
Non-renounceable Entitlement Offer
Feb 26 2026
Half Yearly Report and Accounts
Jan 30 2026
Quarterly Activities/Appendix 4C Cash Flow Report

Community Chat

Ask AI

6ix6ixAIEvents